Catalase activity in liver homogenates was studied in normal and low endotoxin (LPS)-responder mice treated with various doses of LPS from S. typhimurium B or bearing tumours induced by 3-methylcholanthrene. In normal LPS-responder (C3H/f) mice a dose of 40 pg LPS or tumour induction caused a reduction of catalase activity of about 50%. In low responder (C3H/HeJ) mice a reduction of the enzyme activity of over 40% was observed at a dose of 200 pg LPS. Tumour induction had no effect. In tumour-bearing mice of both strains the presence of a tumour seemed to interfere with the ability of LPS to depress hepatic catalase activity. Since a reduction of the enzyme activity in response to LPS or tumour induction seemed to be influenced by the LPS responsivenessof the mice, this study suggests that there could be common mediators of this effect. It is also possible that tumour induction might influence host responses to LPS.
I N T R O D U C T I O N
It is well established that tumour-bearing rats and rats treated with tumour extracts, bacteria, bacterial endotoxin (LPS), or with activators of the reticuloendothelial system (RES) develop reduced liver and kidney catalase activity, increased organ weights, alterations of iron metabolism and other systemic effects (Kampschmidt & Clabaugh, 1960 ;  Kampschmidt et a/., 1960; Kampschmidt et a/., 1962; Kampschmidt & Upchurch, 1963) . These reports suggested that the RES could be the common mediator of all these effects.
Preliminary studies in our laboratory have shown that in normal LPS-responder mice (C3H/f, DBA/2J, C57BL/6) bearing either a chemically induced-tumour or the E hrlich ascites tumour, hepatic catalase activity was significantly reduced. In contrast, low LPS responder C3H/HeJ mice, bearing the Ehrlich ascites tumour, did not show a reduction in hepatic catalase activity. These observations led us to investigate the relationship between LPS sensitivity and hepatic catalase activity in low (C3H/HeJ) and normal (C3H/f) LPS-responder mice. Hepatic catalase activity was determined in both mouse strains treated with various doses of LPS from S . tjphimurium B, or bearing a 3-methylcholanthrene (3-MCA)-induced tumour. The combined effects of LPS treatment and tumour induction were also studied.
METHODS
Mice srruins. C3HIHeJ were purchased from the Jackson Laboratory, Bar Harbor. Me., USA. C3H/f mice were LPS. LPS from S . rjphinturiuni B was purchased from Difco Laboratories, Detroit, Mich., USA. The following Curcinogen. 3-MCA and the carcinogen vehicle, trioctanoin (Trioc), were purchased from Eastman Organic purchased from Microbiological Associates, Walkersville. Md., USA.
concentrations were prepared in distilled water (mg ml-I ) : 0.4, 1.0 and 2.0. Chemicals, Rochester, N.Y., USA. 3-MCA was prepared at ;I concentration of 6 mg ml-' Ahhreiiarions: LPS, lipopolysaccharide (bacterial endotoxin): 3-MCA, 3-methylcholanthrene; RES, reticuloendot helial system.
I . G A R C I A -C A S T R O A N D L . G A Y A

E.t-perimenraIprocedures.
To study the effects of various doses of LPS on the hepatic catalase activity of 6 8 week old male and female mice of both strains, the mice were divided into four groups with no less than 17 mice per group. One group was the uninoculated control. Each animal in the remaining three groups was inoculated intraperitoneally with a dose of LPS equal to 40yg, 1OOyg and 200yg, respectively. At 16 h, mice from experimental and control groups were killed and hepatic catalase activity was determined.
To study hepatic catalase activity of mice bearing 3-MCA-induced timours or the combined effect of tumour induction and LPS treatment, 6-8 week old male and female mice were divided into four groups, with no less than 16 mice per group. Two groups served as controls, an uninoculated group and a group inoculated subcutaneously with 0.1 ml Trioc. A third group was inoculated subcutaneously with 600 yg 3-MCA in trioctanoin. After these mice had developed tumours of at least 2.5 cm in diameter, they were killed and hepatic catalase activity was determined. A fourth group of tumour-bearing mice was inoculated intraperitoneally with a dose of LPS that was found to depress hepatic catalase activity. This dose was 40 pg for the C3H/f mice and 200 yg for the C3H/HeJ mice. At 16 h after LPS treatment, hepatic catalase activity was determined.
Tumour incidence in both strains of mice was 90% at 6 m after 3-MCA inoculation. Only livers of mice with intact tumours were used for hepatic catalase activity determination. Liversof mice with opened tumours were not used for enzyme activity determination in order to reduce the possibility of bacterial contamination of the mice.
Determination ofhepatic caralase actiuity. Sodium perborate (NaB02. 3 H 2 0 . H,Oz) was used as the substrate for liver catalase. (Thomson et a/., 1978) . Liver homogenates of control and experimental mice were prepared at a concentration of 32 mg homogenate ml-in 0.05 M-phosphate buffer, pH 7.0. Homogenates were centrifuged at 3000g for 5 min at 4 "C. Reaction mixtures consisted of 2.8 ml phosphate buffer (0.05 M, pH 7.4), 10 pl supernatant of the liver homogenate and 200 y1 0.1 M-sodium perborate. The disappearance of the perborate was followed at 220nm in a Bausch & Lomb spectrophotometer (Model 710) connected to a Haake constant temperature circulator (30 "C). First order rate constants were determined for each mixture and the values obtained were expressed per yg protein. The concentration of protein in the liver homogenate supernatants was determined by the Lowry method using egg albumin as a standard.
Statistical analysis. A three-way analysis of variance without replication was used to determine significant differences among strains, sex and treatments. A one-way analysis of variance without replication was used to determine significant differences among treatments in each strain of mice. The Student-Newman-Keuls multiple range test was used to determine significant differences between groups within each strain. No significant differences were found between sex, mice strains and between uninoculated control groups and control groups inoculated with Trioc. The data presented are the combined values for both sexes and for both control groups where two control groups were used.
R E S U L T S A N D D I S C U S S I O N
A significant (P <0-001) reduction in hepatic catalase activity of about 50% was observed in normal LPS-responder mice (C3H/f) at a dose of 40 pg LPS. Doses of 100 and 200 pg had no effect. In the low LPS-responder (C3H/HeJ) mice, a dose of LPS (200 pg) five times higher than that required for normal mice caused a significant reduction (P < 0.001) in the enzyme activity of over 40%; in these mice doses of 40 and 100 pg had no effect (Table 1) . These results suggest that the reduction of hepatic catalase activity effected by LPS might be related to the genetic control of LPS responsiveness. Studies with normal and low LPS-responder mice have indicated that inflammatory responses and leukopaenia are dose-dependent effects of LPS. Unresponsiveness of normal mice to relatively higher doses of LPS have been reported previously. However, no clear explanation has been proposed other than attributing the unresponsiveness to a toxic effect (Snyderman & Verghese, 1980) . The hyporesponsiveness of C3H/HeJ mice to various biological effects of LPS has been related to genetic defects of macrophage function (Rosenstreich & Vogel, 1980) and LPS sensitivity has been demonstrated to have a very close relationship to RES activation (Di Luzio et al., 1980) . Future studies should determine if the reduction of hepatic catalase activity by LPS is mediated through macrophages or through some other component of the immune system. Tumour-bearing C3H/f mice showed a significant (P < 0.001) reduction of hepatic catalase activity of about 50%. This inhibition was comparable to that of mice treated with 40 pg LPS alone. When tumour-bearing mice of this strain were treated with 40 pg LPS, catalase activity was also inhibited significantly compared to control mice, but remained essentially the same as in tumour-bearing mice. In marked contrast, tumour-bearing C3H/HeJ mice did not show depression of hepatic catalase activity even when treated with 200pg LPS (Table 1) . Previous studies have shown that C3H/HeJ mice showed no depression of hepatic catalase activity when bearing a spontaneous mammary tumour. Inhibition was observed only in the presence of a relatively large and invasive lymphosarcoma (Kaplan & Groves, 1972) . This difference might have been the result of increased stimulation of possible mediators due to the invasiveness of the lymphosarcoma. Our results indicate that the presence of a 3-MCA-induced tumour affects liver catalase activity to the same degree as low doses of LPS by reducing the enzyme activity of normal LPS-responder mice but not of low responder mice. This suggests that certain tumours might depress the activity of liver catalase by a mechanism similar to LPS. Moreover, it appears that the presence of a tumour interferes with the ability of LPS to depress liver catalase activity.
Previous studies have suggested that macrophages are primary targets for LPS responsiveness (Peavy & Brandon, 1980) . It has also been demonstrated that tumour factors can depress the chemotactic and inflammatory response to LPS of mouse macrophages (Pike & Snyderman, 1976) , as well as LPS responses of spleen cells (Watanabe, 1979) .
The reduction in liver catalase activity and other systemic effects of tumours on the host have been ascribed to tumour-specific toxins, called toxohormones (Nakahara & Fukuoka, 1958 ; Nakahara, 1960 The results of our study should serve as a starting point to elucidate some of the mechanisms involved in the systemic effects of tumours on the host.
